BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 19113831)

  • 1. Development of a nanoLC LTQ orbitrap mass spectrometric method for profiling glycans derived from plasma from healthy, benign tumor control, and epithelial ovarian cancer patients.
    Bereman MS; Williams TI; Muddiman DC
    Anal Chem; 2009 Feb; 81(3):1130-6. PubMed ID: 19113831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative profiling of N-glycans isolated from serum samples of ovarian cancer patients and analyzed by microchip electrophoresis.
    Mitra I; Alley WR; Goetz JA; Vasseur JA; Novotny MV; Jacobson SC
    J Proteome Res; 2013 Oct; 12(10):4490-6. PubMed ID: 23984816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
    Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
    Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum glycome profiling: a biomarker for diagnosis of ovarian cancer.
    Biskup K; Braicu EI; Sehouli J; Fotopoulou C; Tauber R; Berger M; Blanchard V
    J Proteome Res; 2013 Sep; 12(9):4056-63. PubMed ID: 23889230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a hydrophilic interaction liquid chromatography coupled with matrix-assisted laser desorption/ionization-mass spectrometric imaging platform for N-glycan relative quantitation using stable-isotope labeled hydrazide reagents.
    Chen Z; Zhong X; Tie C; Chen B; Zhang X; Li L
    Anal Bioanal Chem; 2017 Jul; 409(18):4437-4447. PubMed ID: 28540462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MALDI Mass Spectrometry Imaging of Early- and Late-Stage Serous Ovarian Cancer Tissue Reveals Stage-Specific N-Glycans.
    Briggs MT; Condina MR; Ho YY; Everest-Dass AV; Mittal P; Kaur G; Oehler MK; Packer NH; Hoffmann P
    Proteomics; 2019 Nov; 19(21-22):e1800482. PubMed ID: 31364262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative glycomic profiling of isotopically permethylated N-glycans by liquid chromatography/electrospray ionization mass spectrometry.
    Hu Y; Desantos-Garcia JL; Mechref Y
    Rapid Commun Mass Spectrom; 2013 Apr; 27(8):865-77. PubMed ID: 23495056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycomics analysis of serum: a potential new biomarker for ovarian cancer?
    Leiserowitz GS; Lebrilla C; Miyamoto S; An HJ; Duong H; Kirmiz C; Li B; Liu H; Lam KS
    Int J Gynecol Cancer; 2008; 18(3):470-5. PubMed ID: 17655680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample preparation for mass spectrometric analysis of human serum N-glycans using hydrophilic interaction chromatography-based solid phase extraction.
    Cao L; Zhang Y; Chen L; Shen A; Zhang X; Ren S; Gu J; Yu L; Liang X
    Analyst; 2014 Sep; 139(18):4538-46. PubMed ID: 25068150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and confirmation of differentially expressed fucosylated glycoproteins in the serum of ovarian cancer patients using a lectin array and LC-MS/MS.
    Wu J; Xie X; Liu Y; He J; Benitez R; Buckanovich RJ; Lubman DM
    J Proteome Res; 2012 Sep; 11(9):4541-52. PubMed ID: 22827608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ascites N-glycome of epithelial ovarian cancer patients.
    Biskup K; Braicu EI; Sehouli J; Tauber R; Blanchard V
    J Proteomics; 2017 Mar; 157():33-39. PubMed ID: 28188862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a robust and high throughput method for profiling N-linked glycans derived from plasma glycoproteins by NanoLC-FTICR mass spectrometry.
    Bereman MS; Young DD; Deiters A; Muddiman DC
    J Proteome Res; 2009 Jul; 8(7):3764-70. PubMed ID: 19435342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly accurate detection of ovarian cancer using CA125 but limited improvement with serum matrix-assisted laser desorption/ionization time-of-flight mass spectrometry profiling.
    Tiss A; Timms JF; Smith C; Devetyarov D; Gentry-Maharaj A; Camuzeaux S; Burford B; Nouretdinov I; Ford J; Luo Z; Jacobs I; Menon U; Gammerman A; Cramer R
    Int J Gynecol Cancer; 2010 Dec; 20(9):1518-24. PubMed ID: 21370595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lectin affinity workflow targeting glycosite-specific, cancer-related carbohydrate structures in trypsin-digested human plasma.
    Drake PM; Schilling B; Niles RK; Braten M; Johansen E; Liu H; Lerch M; Sorensen DJ; Li B; Allen S; Hall SC; Witkowska HE; Regnier FE; Gibson BW; Fisher SJ
    Anal Biochem; 2011 Jan; 408(1):71-85. PubMed ID: 20705048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery.
    Alley WR; Madera M; Mechref Y; Novotny MV
    Anal Chem; 2010 Jun; 82(12):5095-106. PubMed ID: 20491449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.
    Everest-Dass AV; Briggs MT; Kaur G; Oehler MK; Hoffmann P; Packer NH
    Mol Cell Proteomics; 2016 Sep; 15(9):3003-16. PubMed ID: 27412689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microgradient separation technique for purification and fractionation of permethylated N-glycans before mass spectrometric analyses.
    Rehulka P; Zahradnikova M; Rehulkova H; Dvorakova P; Nenutil R; Valik D; Vojtesek B; Hernychova L; Novotny MV
    J Sep Sci; 2018 May; 41(9):1973-1982. PubMed ID: 29392831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of glycan variation on glycoproteins from serum by the reverse lectin-based ELISA assay.
    Wu J; Zhu J; Yin H; Buckanovich RJ; Lubman DM
    J Proteome Res; 2014 Apr; 13(4):2197-204. PubMed ID: 24575722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer diagnosis by analysis of serum N-glycans using MALDI-TOF mass spectroscopy.
    Lee SB; Bose S; Ahn SH; Son BH; Ko BS; Kim HJ; Chung IY; Kim J; Lee W; Ko MS; Lee K; Chang S; Park HS; Lee JW; Kim DC
    PLoS One; 2020; 15(4):e0231004. PubMed ID: 32271809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometric screening of ovarian cancer with serum glycans.
    Kim JH; Park CW; Um D; Baek KH; Jo Y; An H; Kim Y; Kim TJ
    Dis Markers; 2014; 2014():634289. PubMed ID: 24648610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.